Welcome to the upgraded MacSphere! We're putting the finishing touches on it; if you notice anything amiss, email macsphere@mcmaster.ca

The unique characteristics of COVID-19 coagulopathy

Simple item page
dc.contributor.authorIba T
dc.contributor.authorLevy JH
dc.contributor.authorConnors JM
dc.contributor.authorWarkentin TE
dc.contributor.authorThachil J
dc.contributor.authorLevi M
dc.date.accessioned2021-02-24T17:02:00Z
dc.date.available2021-02-24T17:02:00Z
dc.date.issued2020-12
dc.date.updated2021-02-24T17:01:58Z
dc.description.abstractThrombotic complications and coagulopathy frequently occur in COVID-19. However, the characteristics of COVID-19-associated coagulopathy (CAC) are distinct from those seen with bacterial sepsis-induced coagulopathy (SIC) and disseminated intravascular coagulation (DIC), with CAC usually showing increased D-dimer and fibrinogen levels but initially minimal abnormalities in prothrombin time and platelet count. Venous thromboembolism and arterial thrombosis are more frequent in CAC compared to SIC/DIC. Clinical and laboratory features of CAC overlap somewhat with a hemophagocytic syndrome, antiphospholipid syndrome, and thrombotic microangiopathy. We summarize the key characteristics of representative coagulopathies, discussing similarities and differences so as to define the unique character of CAC.
dc.identifier.doihttps://doi.org/10.1186/s13054-020-03077-0
dc.identifier.issn1364-8535
dc.identifier.issn1364-8535
dc.identifier.urihttp://hdl.handle.net/11375/26238
dc.publisherSpringer Science and Business Media LLC
dc.rightsThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
dc.rights.licenseAttribution - CC BY
dc.rights.uri2
dc.subjectAntiphospholipid syndrome
dc.subjectCOVID-19
dc.subjectCoagulopathy
dc.subjectDisseminated intravascular coagulation
dc.subjectHemophagocytic syndrome
dc.subjectThrombotic microangiopathy
dc.subjectBetacoronavirus
dc.subjectBlood Coagulation Disorders
dc.subjectBlood Coagulation Tests
dc.subjectCOVID-19
dc.subjectCoronavirus Infections
dc.subjectHumans
dc.subjectInflammation Mediators
dc.subjectPandemics
dc.subjectPlatelet Aggregation
dc.subjectPneumonia, Viral
dc.subjectSARS-CoV-2
dc.titleThe unique characteristics of COVID-19 coagulopathy
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
The unique characteristics of COVID-19 coagulopathy.pdf
Size:
964.84 KB
Format:
Adobe Portable Document Format
Description:
Published version
Download

Collections

Faculty Publications (via McMaster Experts)